Chelsea v Morecambe, Leicester v QPR, and more: FA Cup third round – clockwatch
Lindsey Vonn places impressive sixth in first World Cup downhill in six years
Protesters in Calais condemn UK policies to stop Channel crossings
Venezuelan opposition candidate accuses Nicolás Maduro of coup
Male mosquitoes to be genetically engineered to poison females with semen in Australian research
Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business
AstraZeneca is buying its first vaccine company in a $1.1bn deal that will expand the vaccine and immune therapy business it set up during the Covid pandemic.
Britain’s biggest drugmaker has agreed to take over the Seattle-based company Icosavax, which is developing a potential vaccine for two common respiratory diseases.
More Stories
Memo to Trump: US telecoms is vulnerable to hackers. Please hang up and try again | John Naughton
Bizarre Australian mole even more unusual than first thought, new research reveals
Male mosquitoes to be genetically engineered to poison females with semen in Australian research